[Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].

Autors determine the clinical effectiveness of including cytoflavin in intensive care of patients with severe combined traumatic brain injury. A prospective blind randomized controlled study was conducted on two groups involving 101 participants. In group I (58 patients), the intensive care was standard. In group II (43 patients), the intensive care included cytoflavin which was added beginning with the second day of the post-traumatic period. For this purpose, 10 ml of cytoflavin was dissolved in 200 ml of 10% aqueous solution of glucose and was administered intravenously at a speed of 140 drops (7 ml) per minute within 7 days. The use of cytoflavin in complex intensive care of severe combined traumatic brain injury within two days after injury (with the proper correction of blood circulation and respiration) reduced the number of multiple organ dysfunctions, the number is purulent-septic complications, the time of regress in multiple organ dysfunctions, and the reanimation period in intensive care department on the average by a factor of 1.4 - 1.6 (p < 0.005).

[Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].

Research objective--determination of efficiency of intensive care with inclusion Cytoflavin in patients of old age in combined traumatic brain injury. A prospective controlled blind randomized study was conducted. In 1st group (21 people) the patients received a standard intensive care, in 2nd group (18 persons) Cytoflavin was included in complex intensive care. Using Cytoflavin starting from 2 days post-traumatic period (with the correction of blood circulation and respiration) had antioxidant and detoxification effects, contributed to the recovery rate of free radical and metabolic processes, reduced the degree of impairment in the structural-functional state of membranes and restored the conformational structure of membrane proteins in the earlier periods. Reduction in reactions of disadaptation led to regression of multiple organ dysfunctions, restoration the level of consciousness at an earlier date. The number of cases of severe respiratory distress syndrome decreased.

[The use of bioregulator of the cytomedine class--epitalamin--in the treatment of combined craniocerebral trauma]. / Ispol'zovanie bioreguliatora klassa tsitomedinov épitalamina v kompleksnoi intensivnoi terapii sochetannoi cherepno-mozgovoi travmy.

The combined craniocerebral trauma is accompanied by an impaired brain function in respect to regulating the entire organism and extends the neurohumoral processes of metabolism. The use of a bioregulator of the cytomedine class--epitalamin--is an actual trend in the treatment of the above pathology.